Abstract:
BACKGROUND : Input from end-users during preclinical phases can support market fit for new HIV prevention technologies.
With several long-acting pre-exposure prophylaxis (PrEP) implants in development, we aimed to understand
young women’s preferences for PrEP implants to inform optimal design.
METHODS : We developed a discrete choice experiment and surveyed 800 young women in Harare, Zimbabwe and
Tshwane, South Africa between September–November 2020. Women aged 18–30 years who were nulliparous, postpartum,
or exchanged sex for money, goods or shelter in prior year were eligible; quotas were set for each subgroup.
The DCE asked participants to choose between two hypothetical implants for HIV prevention in a series of nine
questions. Implants were described by: size, number of rods and insertion sites, duration (6-months, 1-year, 2-years),
flexibility, and biodegradability. Random-parameters logit models estimated preference weights.
RESULTS : Median age was 24 years (interquartile range 21–27). By design, 36% had used contraceptive implants. Duration
of protection was most important feature, with strong preference for a 2-year over 6-month implant. In Zimbabwe,
the number of rods/insertion sites was second most important and half as important as duration. Nonetheless,
to achieve an implant lasting 2-years, 74% were estimated to accept two rods, one in each arm. In South Africa,
preference was for longer, flexible implants that required removal, although each of these attributes were one-third
as important as duration. On average, biodegradability and size did not influence Zimbabwean women’s choices.
Contraceptive implant experience and parity did not influence relative importance of attributes.
CONCLUSIONS : While duration of protection was a prominent attribute shaping women’s choices for PrEP implants,
other characteristics related to discreetness were relevant. Optimizing for longest dosing while also ensuring minimal
detection of implant placement seemed most attractive to potential users.
